US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings Inc.

0.0480

-0.0050-9.43%

Volume:433.27K

Turnover:21.10K

Market Cap:- -

PE:- -

High:0.0578

Open:0.0530

Low:0.0433

Close:0.0530

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Tevogen Bio Holdings Inc.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://semperparatusspac.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVGNW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.048,"timestamp":1743448894658,"preClose":0.053,"halted":0,"volume":433269,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.005,"latestTime":"03-31 15:21:41 EDT","open":0.053,"high":0.0578,"low":0.0433,"amount":21102.489693396,"amplitude":0.273585,"askPrice":0.058,"askSize":100,"bidPrice":0.046,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.053,"volumeRatio":2.194582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.194582,"shares":0,"dividePrice":0,"high":0.0578,"amplitude":0.273585,"preClose":0.053,"low":0.0433,"week52Low":0.0099,"pbRate":"--","week52High":0.1499,"institutionHeld":0,"latestPrice":0.048,"committee":0.960784,"eps":0,"divideRate":0,"volume":433269,"delay":0,"ttmEps":0,"open":0.053,"prevYearClose":0.054,"prevWeekClose":0.0579,"prevMonthClose":0.0669,"prevQuarterClose":0.054,"fiveDayClose":0.0638,"twentyDayClose":0.065,"sixtyDayClose":0.054},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":0.0643},{"period":"1month","weight":-0.151},{"period":"3month","weight":-0.0186},{"period":"6month","weight":2.8859},{"period":"1year","weight":-0.2982},{"period":"ytd","weight":0.0722}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":1.578518},{"month":2,"riseRate":0.25,"avgChangeRate":0.208292},{"month":3,"riseRate":0.5,"avgChangeRate":0.014357},{"month":4,"riseRate":0,"avgChangeRate":-0.282545},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.106184},{"month":6,"riseRate":0,"avgChangeRate":-0.176798},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.059726},{"month":8,"riseRate":0.333333,"avgChangeRate":0.1125},{"month":9,"riseRate":0,"avgChangeRate":-0.256349},{"month":10,"riseRate":0.333333,"avgChangeRate":1.818294},{"month":11,"riseRate":0,"avgChangeRate":-0.508558},{"month":12,"riseRate":0.333333,"avgChangeRate":0.083737}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{}}}